-
1 Comment
BMGB Capital Corp is currently in a long term downtrend where the price is trading 0.0% below its 200 day moving average.
From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Financial Services sector with a price to sales ratio of 0.0.
BMGB Capital Corp's total revenue sank by nan% to $0 since the same quarter in the previous year.
Its net income has increased by 20.4% to $-18K since the same quarter in the previous year.
Finally, its free cash flow grew by 13.2% to $-22K since the same quarter in the previous year.
Based on the above factors, BMGB Capital Corp gets an overall score of 3/5.
| Exchange | V |
|---|---|
| CurrencyCode | CAD |
| Sector | Financial Services |
| Industry | Shell Companies |
| ISIN | None |
| PE Ratio | None |
|---|---|
| Target Price | None |
| Dividend Yield | 0.0% |
| Market Cap | 460K |
| Beta | 0.06 |
NAVCO Pharmaceuticals Limited manufactures biologically active product line used for wound and bone healing, drug delivery systems, detection technologies, and multiple other uses. It offers aerosol spray, a cream and nano BioActive-Silver. The company is based in Burlington, Canada.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for BMGB-P.V using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
